Jane Street’s Propanc Biopharma PPCB Stock Holding History

Jane Street’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.3K	Buy	25,550 +19,822	+346%	+$42.8K	﹤0.01%	11023
2026 Q1	$15.2K	Buy	+5,728	New	+$34K	﹤0.01%	11242

Other funds holding PPCB

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Jane Street's PPCB Position: Q2 2026 in Review

Jane Street increased its Propanc Biopharma (PPCB) stake by 346% in Q2 2026, buying an estimated $42.8K and bringing the position to 25,550 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11023.

Jane Street first reported a position in PPCB in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

Jane Street held 25,550 shares of Propanc Biopharma worth $38.3K as of Q2 2026.
Jane Street bought 19,822 Propanc Biopharma shares in Q2 2026, an estimated $42.8K.
Propanc Biopharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11023 holding.
Jane Street first reported a position in Propanc Biopharma in Q1 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.